In leukaemia subtypes, ALL - L2 and AML-M3 were most common and in chronic leukaemias CML was most common.
The term leukaemia refers to white blood cell malignancies and a rare case arising from red blood cell precursors in erythroleukaemia.
founder, Prof Charlie Craddock said: "Leukaemia
is the most common form of cancer in children, and almost half of those diagnosed with the disease are under the age of five.
Dr Willmore said: "Some patients with chronic lymphocytic leukaemia
become very ill and the cancer becomes resistant to the chemotherapy, so we need new and more effective treatments to overcome this.
Cells in chronic leukaemia
are slightly abnormal and do not function as well as they should do.
There are two main types, known as acute leukaemia
and chronic leukaemia
, with the incidence of both approximately equal.
Fallout from Chernobyl and incidence of childhood leukaemia
in Finland, 1976-92.
Acute Myeloid Leukaemia
Phase 3 Clinical Trial Pipeline Insights
John Seymour MBBS FRACP, Chairman of the Australasian Leukaemia
and Lymphoma Clinical Trials Group said: "The clinical data presented at recent international conferences on the use of Evoltra(R) in elderly patients with AML appear very promising, with encouraging efficacy and good tolerability.
For the innovators of novel and efficacious pharmacotherapy, commercial opportunities within the acute leukaemia
market are rife.
Clofarabine is currently under evaluation by the European Medicines Evaluation Agency (EMEA) for the treatment of relapsed or refractory acute leukaemia
Food and Drug Administration (FDA) has accepted the filing of the New Drug Application (NDA 21-673) for clofarabine for the treatment of refractory or relapsed acute leukaemia
Food and Drug Administration (FDA) for clofarabine for the treatment of refractory or relapsed acute leukaemia
In addition, Bioenvision has commenced large-scale clinical trials of clofarabine as first line therapy in adult acute leukaemia
and in refractory/relapsed pediatric acute leukemia in Europe.
The study authors concluded that "clofarabine is the first deoxyadenosine analog with promising activity in pediatric ALL, pediatric AML and adult acute leukaemia
at doses that are well tolerated.